Differentiation of cGMP-dependent and -independent nitric oxide effects on platelet apoptosis and reactive oxygen species production using platelets lacking soluble guanylyl cyclase

Thromb Haemost. 2011 Nov;106(5):922-33. doi: 10.1160/TH11-05-0319. Epub 2011 Jul 28.

Abstract

Platelet activation is an irreversible process resulting in platelet apoptosis and necrosis, and circulating platelets contain many components of the apoptotic machinery. Cyclic guanosine monophosphate (cGMP) generated by nitric oxide (NO) activated soluble guanylyl cyclase (sGC) plays a crucial role in preventing platelet activation. However, in addition to activation of sGC, cGMP-independent NO effects in platelets have been described. To differentiate between cGMP-dependent and -independent NO effects on platelet apoptosis and reactive oxygen species (ROS) production, we generated platelet-specific sGC-deficient mice (PS-GCKO). Platelet apoptosis was induced by a combination of thrombin/convulxin (Thr/Cvx) and assessed by phosphatidylserine (PS) surface exposure, and loss of the mitochondrial membrane potential. NO-induced inhibition of PS externalisation was mediated only by cGMP-dependent mechanisms. Inhibition of the mitochondrial membrane potential decrease at low NO concentration was also cGMP-dependent but became cGMP-independent at high NO concentrations. In contrast, inhibition of ROS formation at any NO concentration was mediated by cGMP-independent mechanisms, very likely due to direct radical scavenging. NO inhibits platelet apoptosis by cGMP-dependent mechanisms and ROS production by cGMP-independent mechanisms. The PS-GCKO mouse model is an important tool for the differentiation of cGMP-dependent and -independent NO effects on platelets.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis* / drug effects
  • Blood Platelets / drug effects
  • Blood Platelets / enzymology*
  • Crotalid Venoms / pharmacology
  • Cyclic GMP / blood*
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • Guanylate Cyclase / deficiency*
  • Guanylate Cyclase / genetics
  • Humans
  • Lectins, C-Type
  • Membrane Potential, Mitochondrial
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mitochondria / metabolism
  • Mitochondria / pathology
  • Nitric Oxide / blood*
  • Nitric Oxide Donors / pharmacology
  • Phosphatidylserines / blood
  • Platelet Activation* / drug effects
  • Reactive Oxygen Species / blood*
  • Receptors, Cytoplasmic and Nuclear / deficiency*
  • Receptors, Cytoplasmic and Nuclear / genetics
  • Signal Transduction
  • Soluble Guanylyl Cyclase
  • Thrombin / metabolism
  • Uncoupling Agents / pharmacology

Substances

  • Crotalid Venoms
  • Enzyme Inhibitors
  • Lectins, C-Type
  • Nitric Oxide Donors
  • Phosphatidylserines
  • Reactive Oxygen Species
  • Receptors, Cytoplasmic and Nuclear
  • Uncoupling Agents
  • Nitric Oxide
  • convulxin
  • Thrombin
  • Guanylate Cyclase
  • Soluble Guanylyl Cyclase
  • Cyclic GMP